Trial intelligence / Profile preview

Artemether-Lumefantrine Clinical Effectiveness Study

NCT01599000Phase 4Completed

Sponsor
Papua New Guinea Institute of Medical Research
Start
Mar 2011
Primary completion
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lumefantrine in malaria, sponsored by Papua New Guinea Institute of Medical Research. Started Mar 2011; status: completed.

02

Drugs

lumefantrine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT01599000.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01599000.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call